Comparative cardiovascular effects of GLP-1 agonists using real-world data.
Wallia A, O'Brien M, Hakimian S, Kang R, Cooper A, Lancki N, Stephen JJ, Aikman C, Liss D, Parker E, Ackermann RT.
Wallia A, et al. Among authors: lancki n.
Endocrinol Diabetes Metab. 2023 May;6(3):e339. doi: 10.1002/edm2.339. Epub 2023 Feb 24.
Endocrinol Diabetes Metab. 2023.
PMID: 36825925
Free PMC article.